Biotechnology Value Fund Partners - Investor Profile


Primary Address:

Investor Information:

1 Sansome StreetTotal AUM ($MM):Login to Access
San Francisco, CA 60611Equity AUM ($MM):Login to Access
Phone: Login to AccessInvestment Style:Login to Access
Fax: Login to AccessOrientation:Login to Access
Investor Type:Login to Access

Institutional Investor Background


Biotechnology Value Fund Partners LP (BVF Partners LP) is a private investment partnership founded in 1993 by President and Portfolio Manager Mark Lampert. Prior to founding BVF Partners,...

Login now or Register for a Free Account to access full Institutional Investor Background

Investor Regional and/or Country Focus: North America

Founders and Key Executives of Biotechnology Value Fund Partners: Mark N. Lampert

Entities related to Biotechnology Value Fund Partners: Biotechnology Value Fund II LP; Biotechnology Value Fund LP; BVF Inc; BVF Investments LLC; BVF Partners LP

*Denotes that the person or entity is no longer related to the firm.



Biotechnology Value Fund Partners's Top 10 Equity Holdings


Value
Company (Ticker) ($MM) Shares Change % Out
Ligand Pharmaceuticals Inc (LGND) 96.52 3,621,665 39,600 18.52
Ironwood Pharmaceuticals Inc (IRWD) 96.04 5,252,561 -34,566 6.66
Chemocentryx, Inc. (CCXI) 69.47 5,026,766 0 13.90
Rigel Pharmaceuticals Inc (RIGL) 59.06 8,697,997 830,000 10.00
Array Biopharma Inc (ARRY) 56.25 11,431,858 0 12.82
Targacept Inc (TRGT) 26.42 6,171,669 0 18.49
QLT Inc (QLTI) 24.09 2,725,303 -1,646,697 5.46
Cytokinetics Inc (CYTK) 11.76 10,313,435 0 7.73
Pain Therapeutics Inc (PTIE) 11.17 3,257,327 0 7.30
Exelixis Inc (EXEL) 10.13 2,193,000 0 1.19

To See Complete Investor Holdings, Sign-up for a Free-Trial of HedgeTracker's Premium Database

Articles Related to Biotechnology Value Fund Partners


Top Small-Cap Hedge Funds see assets jump by 9.5%; Artal Group and MSD Capital claim top spots

Date: February 15th, 2014
The Top 50 Small-Cap focused hedge funds now manage $25 billion in small-cap assets, having added nearly $2.7 billion in small-cap assets since the end...

Login now or Register for a Free Account to access all Related Articles

Biotechnology Value Fund joins activist battle against Facet Biotech

Date: October 7th, 2009
From this week’s Hedge Fund Solutions Catalyst Equity Research Report, we are highlighting the Biotechnology Value Fund’s investment in immunology...

Login now or Register for a Free Account to access all Related Articles

Return to Free Hedge Fund Investor Directory